Study S001684

An Open-label Single Center Study to Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06301256
Study type: INTERVENTIONAL
Masking: NONE
Status: UNKNOWN
Enrollment: 20
Start: 2024-03-11
Primary completion: 2025-03-11
Lead sponsor: Florida Academic Centers Research and Education, LLC
Conditions: Hidradenitis Suppurativa
Interventions: DRUG:TIRZEPATIDE
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Hidradenitis Suppurativa Clinical Response (HiSCR) 50% [24 Weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0032441	Evaluating Tirzepatide's Therapeutic Potential in Mitigating Obesity-Associated Comorbidities Kahook, Zaneh, NSUWorks (Nova Southeastern University)	2024	Other trial		cites ClinicalTrials.gov:NCT06301256